Routine germline BRCA1 and BRCA2 testing in ovarian carcinoma patients : analysis of the Scottish real life experience
Citation
Rust , K , Spiliopoulou , P , Tang , C Y , Bell , C , Stirling , D , Phang , T H F , Davidson , R , Mackean , M , Nussey , F , Glasspool , R , Reed , N , Sadozye , A , Porteous , M , McGoldrick , T , Ferguson , M , Miedzybrodzka , Z , McNeish , I A & Gourley , C 2018 , ' Routine germline BRCA1 and BRCA2 testing in ovarian carcinoma patients : analysis of the Scottish real life experience ' , BJOG-An International Journal of Obstetrics and Gynaecology , vol. 125 , no. 11 , pp. 1451-1458 . https://doi.org/10.1111/1471-0528.15171
Rights
This is the peer reviewed version of the following article:Rust K, Spiliopoulou P, Tang CY, Bell C, Stirling D, Phang THF, Davidson R, Mackean M, Nussey F, Glasspool RM, Reed NS, Sadozye A, Porteous M, McGoldrick T, Ferguson M, Miedzybrodzka Z, McNeish IA, Gourley C. Routine germline BRCA1 and BRCA2 testing in patients with ovarian carcinoma: analysis of the Scottish real‐life experience. BJOG 2018; 125:1451–1458., which has been published in final form at DOI: 10.1111/1471-0528.15171. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.